...
首页> 外文期刊>Biomaterials >Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells
【24h】

Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cells

机译:等离子纳米气泡增强的内体逃逸过程,可选择性地和指导性地将细胞内化疗递送给耐药性癌细胞

获取原文
获取原文并翻译 | 示例

摘要

Cancer chemotherapies suffer from multi drug resistance, high non-specific toxicity and heterogeneity of tumors. We report a method of plasmonic nanobubble-enhanced endosomal escape (PNBEE) for the selective, fast and guided intracellular delivery of drugs through a self-assembly by cancer cells of separately targeted gold nanoparticles and encapsulated drug (Doxil). The co-localized with Doxil plasmonic nanobubbles optically generated in cancer cells released the drug into the cytoplasm thus increasing the therapeutic efficacy against these drug-resistant cells by 31-fold, reducing drug dose by 20-fold, the treatment time by 3-fold and the non-specific toxicity by 10-fold compared to standard treatment. Thus the PNBEE mechanism provided selective, safe and efficient intracellular drug delivery in heterogeneous environment opening new opportunities for drug therapies.
机译:癌症化学疗法具有多重耐药性,高度的非特异性毒性和肿瘤的异质性。我们报告了等离子体,纳米气泡增强的内体逃逸(PNBEE)的方法,用于选择性,快速和引导细胞内药物通过癌细胞的自组装分别靶向金纳米颗粒和封装的药物(Doxil)。与癌细胞中光学产生的Doxil等离子体纳米气泡的共定位将药物释放到细胞质中,从而使对这些耐药细胞的治疗功效提高了31倍,药物剂量降低了20倍,治疗时间降低了3倍与标准治疗相比,非特异性毒性提高了10倍。因此,PNBEE机制在异质环境中提供了选择性,安全和有效的细胞内药物递送,为药物治疗打开了新的机会。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号